H, K., & W, G. (2003). Characterisation of the 1H and 13C NMR spectra of N-acetylaspartylglutamate and its detection in urine from patients with Canavan disease. Journal of pharmaceutical and biomedical analysis, 31(3), 455. https://doi.org/10.1016/s0731-7085(02)00691-x
Chicago Style (17th ed.) CitationH, Krawczyk, and Gradowska W. "Characterisation of the 1H and 13C NMR Spectra of N-acetylaspartylglutamate and Its Detection in Urine from Patients with Canavan Disease." Journal of Pharmaceutical and Biomedical Analysis 31, no. 3 (2003): 455. https://doi.org/10.1016/s0731-7085(02)00691-x.
MLA (9th ed.) CitationH, Krawczyk, and Gradowska W. "Characterisation of the 1H and 13C NMR Spectra of N-acetylaspartylglutamate and Its Detection in Urine from Patients with Canavan Disease." Journal of Pharmaceutical and Biomedical Analysis, vol. 31, no. 3, 2003, p. 455, https://doi.org/10.1016/s0731-7085(02)00691-x.